Shares of Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) saw an uptick in trading volume on Friday . 23,775 shares were traded during trading, an increase of 332% from the previous session's volume of 5,500 shares.The stock last traded at $73.4446 and had previously closed at $73.9160.
Analyst Ratings Changes
A number of equities analysts have weighed in on the company. BNP Paribas Exane raised Eurofins Scient to an "outperform" rating in a research report on Monday, January 5th. Citigroup reaffirmed a "neutral" rating on shares of Eurofins Scient in a research report on Monday, February 2nd. One equities research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, Eurofins Scient has an average rating of "Hold".
Check Out Our Latest Research Report on ERFSF
Eurofins Scient Stock Down 2.6%
The firm's 50 day moving average is $76.44 and its two-hundred day moving average is $74.94.
Eurofins Scient Company Profile
(
Get Free Report)
Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.
Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Eurofins Scient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.
While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
